UK Markets closed

Alliance Pharma plc (APH.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
103.00-0.80 (-0.77%)
At close: 4:37PM GMT
Currency in GBp

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3123.00
52-week low 372.20
50-day moving average 3102.93
200-day moving average 399.11

Share statistics

Avg vol (3-month) 3855.99k
Avg vol (10-day) 31.12M
Shares outstanding 5534.01M
Implied shares outstanding 6N/A
Float 8529.48M
% held by insiders 16.69%
% held by institutions 166.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.02
Forward annual dividend yield 41.59%
Trailing annual dividend rate 30.02
Trailing annual dividend yield 30.02%
5-year average dividend yield 41.75
Payout ratio 447.77%
Dividend date 3N/A
Ex-dividend date 423 Dec 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 12.29%
Operating margin (ttm)23.22%

Management effectiveness

Return on assets (ttm)4.66%
Return on equity (ttm)6.52%

Income statement

Revenue (ttm)146.72M
Revenue per share (ttm)0.28
Quarterly revenue growth (yoy)27.40%
Gross profit (ttm)82.82M
EBITDA 29.99M
Net income avi to common (ttm)18.04M
Diluted EPS (ttm)1.50
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)27.39M
Total cash per share (mrq)0.05
Total debt (mrq)136.49M
Total debt/equity (mrq)48.72
Current ratio (mrq)2.20
Book value per share (mrq)0.53

Cash flow statement

Operating cash flow (ttm)39.37M
Levered free cash flow (ttm)21.09M